Fourteen member institutes of Leibniz Health Technologies have been working on concrete technology solutions for pressing medical issues. Together they follow the goal of improving medical care for patients. Through the cross-disciplinary approach, prevention, diagnostics, and treatment converge to increase the quality of life.
The Leibniz research alliance unites competencies from very different scientific fields: from photonics and medicine to microelectronics and materials research to economic research and applied mathematics. This results in health technologies that together with industry, hospitals, insurance, and politics are led to marketability along a complete innovation chain. Simultaneously, Leibniz Health Technologies conducts research on the social and economic impact of new medical technologies to optimize their applicability for users and create wide social acceptance of new technologies.
Demographic changes, a Western lifestyle, and increasing globalization confront health systems with increasing and changing needs in terms of services. An increase in age and lifestyle-related diseases can be expected.
Global commerce and tourism, as well as migration tendencies, also facilitate the fast spread of infections, pathogens, and resistance genes. This requires a new care concept in which prevention, diagnostics, treatment, and aftercare converge and individual treatment plans gain importance.
Leibniz Health Technologies will sustainably accelerate the translation of research results to marketable products via the long-term collaboration of its partners to improve the medical care of patients and thus increase the quality of human life.
Parallel to excellent application-oriented fundamental research in the life sciences and medicine, the economic, social, and ethical consequences of new medical technologies will be researched in a multidisciplinary process.
The Leibniz research alliance facilitates the targeted cross-disciplinary collaboration of institutes from different sections of the Leibniz Association with each other and with external partners such as hospitals and companies to advance the topic of health technologies along the innovation chain from fundamental research to the marketing of solutions and methods via industrial partners.
At the same time, this accompanying research will help recognize possible risks and conflicts early on in the process and allow required corrections to the research agenda to be made.